Quantum-Enhanced Predictive Genomics Global Market Report 2025
상품코드:1855962
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
양자 확장 예측 유전체학 시장 규모는 최근 급격하게 확대하고 있습니다. 2024년 14억 5,000만 달러에서 2025년에는 19억 5,000만 달러로, CAGR 34.1%로 성장합니다. 지난 기간 중의 성장은 정밀의료에 대한 수요 증가, 유전체 데이터의 복잡성 증가, 양자 컴퓨팅에 대한 투자 확대, 질병 예측에 대한 적용 확대, 기술과 헬스케어 부문 간의 협력 강화가 원동력이 되었습니다.
양자 확장 예측 유전체학 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 연평균 성장률(CAGR) 33.8%로 62억 6,600만 달러로 성장할 것입니다. 예측 기간의 성장은 개인 맞춤형 헬스케어의 확산, AI와 양자 유전체학의 통합 발전, 질병 조기 발견에 대한 관심 증가, 정부 및 민간 R&D 자금 증가, 고급 유전체 데이터세트의 광범위한 가용성 등에 힘입어 성장세를 이어갈 것으로 보입니다. 이 시기의 주요 동향으로는 양자 머신러닝 모델의 발전, 유전체 데이터 암호화 및 보안 혁신, 멀티오믹스와 양자 분석의 통합, 클라우드 기반 양자 유전체학 플랫폼의 개발, 양자 기술 기업과 생명공학 기업의 협업 등을 꼽을 수 있습니다.
양자 확장 예측 유전체학은 복잡한 유전체 데이터 분석에 양자 컴퓨팅을 활용하여 질병 위험, 치료 효과, 기타 건강 결과를 보다 빠르고 정확하게 예측할 수 있습니다. 이 접근법은 기존 방법으로는 간과하기 쉬운 대규모 유전자 데이터세트의 패턴을 식별하여 바이오마커 탐색 및 맞춤형 의료를 지원합니다.
양자 확장 예측 유전체학의 주요 기술에는 양자 컴퓨팅, 양자 머신러닝, 양자암호화 및 관련 툴이 포함됩니다. 양자컴퓨팅은 복잡한 유전체 데이터를 빠르게 분석 및 해석할 수 있도록 설계된 첨단 계산 플랫폼입니다. 이 솔루션은 클라우드 기반 또는 On-Premise 환경에서 구축할 수 있으며, 제약회사, 생명공학 기업, 연구기관, 의료 서비스 프로바이더 및 기타 유전체학 및 정밀의료 관련 조직에서 사용하고 있습니다.
2025년 봄, 미국의 갑작스러운 관세 인상과 그에 따른 무역 마찰은 헬스케어 분야, 특히 중요한 의료기기, 진단 기기, 의약품 공급에 심각한 영향을 미치고 있습니다. 병원과 의료 서비스 프로바이더들은 수입 수술기구, 영상 진단 장비, 주사기, 카테터 등 소모품의 비용 상승에 직면해 있습니다. 이러한 비용 상승은 의료 예산을 압박하고 있으며, 일부 의료기관은 장비 업그레이드를 늦추거나 환자에게 비용을 전가하고 있습니다. 또한 원자재 및 부품에 대한 관세는 필수적인 의약품 및 의료기기의 생산을 방해하여 공급망 병목현상을 유발하고 있습니다. 이에 대해 업계는 조달 전략을 다양화하고, 가능한 한 현지 생산을 촉진하고, 생명을 구하는 의료 제품에 대한 관세 면제를 옹호하고 있습니다.
이 조사 보고서는 양자 확장 예측 유전체학 산업 세계 시장 규모, 지역 점유율, 양자 확장 예측 유전체학 시장 점유율을 가진 경쟁사, 상세한 양자 확장 예측 유전체학 시장 부문, 시장 동향, 비즈니스 기회 등 양자 확장 예측 유전체학 시장 통계를 제공합니다. Business Research Company의 새로운 보고서 시리즈 중 하나입니다. 이 양자 확장 예측 유전체학 시장 조사 보고서는 업계의 현재와 미래 시나리오에 대한 자세한 분석을 통해 필요한 모든 것을 완벽하게 전망합니다.
맞춤형 의료에 대한 수요 증가는 양자 확장 예측 유전체학 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적, 생물학적, 임상적 프로파일에 따라 의료, 치료, 예방 전략을 조정하는 것을 말합니다. 맞춤형 의료에 대한 수요 증가는 치료 효과를 향상시킬 수 있는 능력에 기인하는 바가 큽니다. 환자의 유전적 체질에 맞춘 치료는 더 나은 결과와 부작용 감소로 이어지는 경우가 많습니다. 양자 확장 예측 유전체학은 복잡한 유전체 데이터를 초고속으로 분석할 수 있게 함으로써 임상의가 정밀하고 개인화된 치료 계획을 수립할 수 있게 해주고, 이에 중요한 역할을 하고 있습니다. 예를 들어 2024년 NHS 잉글랜드는 NHS 유전체 의료 서비스를 통해 81만 건 이상의 개인 맞춤형 게놈 검사가 환자에게 제공되었다고 보고했는데, 이는 전년 대비 8% 증가한 수치로, 유전체 기반 치료에 대한 수요 증가를 반영합니다. 이에 따라 맞춤형 의료에 대한 수요가 양자 확장 예측 유전체학 시장의 성장을 가속할 것으로 예측됩니다.
양자 확장 예측 유전체학 시장의 주요 기업은 유전자 변이 식별을 가속화하고, 맞춤형 의료에서 예측 정확도를 높이고, 복잡한 유전체 데이터세트를 보다 빠르고 정확하게 분석할 수 있도록 하기 위해 하이스루풋 유전체 데이터 처리와 같은 혁신에 집중하고 있습니다. 하이스루풋 유전체 데이터 처리란 첨단 계산 기법을 이용하여 유전체 서열을 신속하고 대규모로 분석하는 것을 말합니다. 예를 들어 2025년 6월, 독일에 본사를 둔 노마 그룹(Norma Group)은 공학적이고 표준화된 접합 및 유체 처리 기술을 전문으로 하는 기업으로, 대규모 유전체 분석에 양자 알고리즘을 적용하기 위해 서울대학교 분당서울대학교병원(SNUBH)과 파트너십을 맺었습니다. 이번 공동연구는 양자적 조합 최적화를 통해 유전자 돌연변이 검출을 가속화하고, 기존 컴퓨팅 방법보다 유전체 데이터 처리 속도와 정확도를 향상시키는 것을 목표로 하고 있습니다. 주요 용도로는 정밀진단, 개인 맞춤형 치료 계획, 암 및 신경질환 등의 유전적 위험도 평가 등이 있습니다.
2025년 8월, 영국의 소프트웨어 회사인 Quantinuum은 웰컴 싱어 연구소와 협력하여 유전체학 분야의 양자 컴퓨팅 용도를 추진합니다. 이번 제휴는 싱어연구소의 Wellcome Leap Quantum for Bio(Q4Bio) 챌린지의 일환으로, 양자 기반 유전체 분석 연구를 지원하기 위한 세계 차원의 노력의 일환입니다. 웰컴생거연구소는 양자 확장 예측 유전체학 솔루션 개발에 주력하고 있습니다.
양자 확장 예측 유전체학 시장은 임상 의사결정 지원 서비스, 종양에 특화된 예측 유전체 분석 서비스, 멀티오믹스 통합 서비스 등의 서비스를 제공하는 사업체가 얻는 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치가 포함됩니다. 양자 확장 예측 유전체학 시장에는 양자 파워형 후성유전체 예측 툴, 양자 통합형 개인맞춤형 예방의학 툴, 양자 강화형 합성생물학 설계 플랫폼의 매출이 포함됩니다. 이 시장의 가치는 '팩토리 게이트' 가치, 즉 상품의 제조업체 또는 제작자가 다른 사업자(다운스트림 제조업체, 도매업체, 유통업체, 소매업체 포함) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 양자 확장 예측 유전체학 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 양자 확장 예측 유전체학 시장 : 성장률 분석
세계의 양자 확장 예측 유전체학 시장 실적 : 규모와 성장, 2019-2024
세계의 양자 확장 예측 유전체학 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 양자 확장 예측 유전체학 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 양자 확장 예측 유전체학 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
양자 컴퓨팅
양자 기계학습
양자암호
기타 기술
세계의 양자 확장 예측 유전체학 시장 : 배포 모드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
온프레미스
클라우드 기반
세계의 양자 확장 예측 유전체학 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
질환 리스크 평가
Drug Discovery
맞춤형 의료
게놈 데이터 해석
기타 용도
세계의 양자 확장 예측 유전체학 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제약·바이오테크놀러지 기업
연구기관
헬스케어 프로바이더
기타 최종사용자
세계의 양자 확장 예측 유전체학 시장 : 서브 세분화 양자 컴퓨팅, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
게이트 기반 양자 컴퓨팅
양자 어닐링
트포로지칼 양자 컴퓨팅
포토닉 양자 컴퓨팅
세계의 양자 확장 예측 유전체학 시장 : 서브 세분화 양자 기계학습, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
지도 학습
비지도 학습
강화 학습
딥러닝
세계의 양자 확장 예측 유전체학 시장 : 서브 세분화 양자암호, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
양자 열쇠 배포
양자 난수 생성
양자 시큐어 통신
포스트 양자암호
세계의 양자 확장 예측 유전체학 시장 : 서브 세분화 기타 기술, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
양자 센서
양자 시뮬레이션
양자 네트워킹
하이브리드 양자 고전 시스템
제7장 지역별·국가별 분석
세계의 양자 확장 예측 유전체학 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 양자 확장 예측 유전체학 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
양자 확장 예측 유전체학 시장 : 경쟁 구도
양자 확장 예측 유전체학 시장 : 기업 개요
Google LLC Overview, Products and Services, Strategy and Financial Analysis
Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
Alibaba Group Holding Limited Overview, Products and Services, Strategy and Financial Analysis
Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
F. Hoffmann-La Roche AG
Accenture plc
IBM Corporation
Pfizer Inc.
Bayer AG
AstraZeneca plc
GlaxoSmithKline plc
Honeywell International Inc.
Fujitsu Limited
Eviden
Xanadu Quantum Technologies Inc.
Pasqal SA
Rigetti Computing Inc.
IonQ Inc.
D-Wave Systems Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
양자 확장 예측 유전체학 시장 2029 : 새로운 기회를 제공하는 국가
양자 확장 예측 유전체학 시장 2029 : 새로운 기회를 제공하는 부문
양자 확장 예측 유전체학 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Quantum-enhanced predictive genomics involves using quantum computing to analyze complex genomic data, enabling faster and more precise predictions of disease risk, treatment response, and other health outcomes. This approach identifies patterns in large-scale genetic datasets that conventional methods may overlook, supporting biomarker discovery and personalized medicine.
The primary technologies in quantum-enhanced predictive genomics include quantum computing, quantum machine learning, quantum cryptography, and related tools. Quantum computing consists of advanced computational platforms designed for rapid analysis and interpretation of complex genomic datasets. These solutions can be deployed in cloud-based or on-premises environments and are used by pharmaceutical and biotechnology companies, research institutes, healthcare providers, and other organizations engaged in genomics and precision medicine.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The quantum-enhanced predictive genomics market research report is one of a series of new reports from The Business Research Company that provides quantum-enhanced predictive genomics market statistics, including the quantum-enhanced predictive genomics industry global market size, regional shares, competitors with the quantum-enhanced predictive genomics market share, detailed quantum-enhanced predictive genomics market segments, market trends, and opportunities, and any further data you may need to thrive in the quantum-enhanced predictive genomics industry. This quantum-enhanced predictive genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The quantum-enhanced predictive genomics market size has grown exponentially in recent years. It will grow from $1.45 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate (CAGR) of 34.1%. The growth during the historic period is driven by rising demand for precision medicine, increasing complexity of genomic data, growing investments in quantum computing, expanding applications in disease prediction, and stronger collaborations between technology and healthcare sectors.
The quantum-enhanced predictive genomics market size is expected to see exponential growth in the next few years. It will grow to $6.26 billion in 2029 at a compound annual growth rate (CAGR) of 33.8%. The projected growth in the forecast period is supported by wider adoption of personalized healthcare, greater integration of AI with quantum genomics, increased focus on early disease detection, rising government and private R&D funding, and broader availability of advanced genomic datasets. Key trends in this period include advancements in quantum machine learning models, innovations in genomic data encryption and security, integration of multi-omics with quantum analytics, development of cloud-based quantum genomics platforms, and collaborations between quantum technology firms and biotechnology companies.
The increasing demand for personalized medicine is anticipated to drive the growth of the quantum-enhanced predictive genomics market. Personalized medicine involves tailoring medical care, treatments, and prevention strategies based on an individual's unique genetic, biological, and clinical profile. The rise in demand for personalized medicine is largely due to its ability to improve treatment effectiveness. Therapies that are tailored to a patient's genetic makeup often lead to better outcomes and fewer side effects. Quantum-enhanced predictive genomics plays a key role in this by enabling ultra-fast analysis of complex genomic data, which allows clinicians to develop highly precise and individualized treatment plans. For example, in 2024, NHS England reported that over 810,000 personalized genomic tests were delivered to patients through the NHS genomic medicine service, an 8% increase from the previous year, reflecting the growing demand for genomic-led care. As a result, the demand for personalized medicine is expected to fuel the growth of the quantum-enhanced predictive genomics market.
Leading companies in the quantum-enhanced predictive genomics market are focusing on innovations such as high-throughput genomic data processing to speed up the identification of genetic variations, enhance predictive accuracy in personalized medicine, and enable faster, more precise analysis of complex genomic datasets. High-throughput genomic data processing refers to the rapid, large-scale analysis of genomic sequences using advanced computational methods. For instance, in June 2025, Norma Group, a Germany-based company specializing in engineered and standardized joining and fluid-handling technology, partnered with Seoul National University Bundang Hospital (SNUBH) to apply quantum algorithms to large-scale genomic analysis. The collaboration aims to accelerate the detection of genetic mutations through quantum-enhanced combinatorial optimization, enhancing both the speed and accuracy of genomic data processing beyond classical computing methods. Key applications include precision diagnostics, personalized treatment planning, and genetic risk assessment for diseases such as cancer and neurological disorders.
In August 2025, Quantinuum, a UK-based software company, teamed up with the Wellcome Sanger Institute to advance quantum computing applications in genomics. This partnership is part of the Sanger Institute's Wellcome Leap Quantum for Bio (Q4Bio) challenge, a global initiative aimed at supporting research in quantum-based genomic analysis. The Wellcome Sanger Institute is focused on developing quantum-enhanced predictive genomics solutions.
Major players in the quantum-enhanced predictive genomics market are Google LLC, Microsoft Corporation, Alibaba Group Holding Limited, Amazon Web Services Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Accenture plc, IBM Corporation, Pfizer Inc., Bayer AG, AstraZeneca plc, GlaxoSmithKline plc, Honeywell International Inc., Fujitsu Limited, Eviden, Xanadu Quantum Technologies Inc., Pasqal SA, Rigetti Computing Inc., IonQ Inc., D-Wave Systems Inc.
North America was the largest region in the quantum-enhanced predictive genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quantum-enhanced predictive genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the quantum-enhanced predictive genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The quantum-enhanced predictive genomics market consists of revenues earned by entities by providing services such as clinical decision support services, oncology-focused predictive genomics services, and multi-omics integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantum-enhanced predictive genomics market includes sales of quantum-powered epigenetic predictive tools, quantum-integrated personalized preventive health tools, and quantum-enhanced synthetic biology design platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Quantum-Enhanced Predictive Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on quantum-enhanced predictive genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for quantum-enhanced predictive genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quantum-enhanced predictive genomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Technology: Quantum Computing; Quantum Machine Learning; Quantum Cryptography; Other Technologies
2) By Deployment Mode: On-Premises; Cloud-Based
3) By Application: Disease Risk Assessment; Drug Discovery; Personalized Medicine; Genomic Data Analysis; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Research Institutes; Healthcare Providers; Other End-Users
Subsegments:
1) By Quantum Computing: Gate Based Quantum Computing; Quantum Annealing; Topological Quantum Computing; Photonic Quantum Computing
2) By Quantum Machine Learning: Supervised Learning; Unsupervised Learning; Reinforcement Learning; Deep Learning
3) By Quantum Cryptography: Quantum Key Distribution; Quantum Random Number Generation; Quantum Secure Communication; Post Quantum Cryptography
4) By Other Technologies: Quantum Sensors; Quantum Simulation; Quantum Networking; Hybrid Quantum Classical Systems
Companies Mentioned: Google LLC; Microsoft Corporation; Alibaba Group Holding Limited; Amazon Web Services Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Accenture plc; IBM Corporation; Pfizer Inc.; Bayer AG; AstraZeneca plc; GlaxoSmithKline plc; Honeywell International Inc.; Fujitsu Limited; Eviden; Xanadu Quantum Technologies Inc.; Pasqal SA; Rigetti Computing Inc.; IonQ Inc.; D-Wave Systems Inc.
3. Quantum-Enhanced Predictive Genomics Market Trends And Strategies
4. Quantum-Enhanced Predictive Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Quantum-Enhanced Predictive Genomics Growth Analysis And Strategic Analysis Framework
5.1. Global Quantum-Enhanced Predictive Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Quantum-Enhanced Predictive Genomics Market Growth Rate Analysis
5.4. Global Quantum-Enhanced Predictive Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Quantum-Enhanced Predictive Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Quantum-Enhanced Predictive Genomics Total Addressable Market (TAM)
6.1. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantum Computing
Quantum Machine Learning
Quantum Cryptography
Other Technologies
6.2. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
On-Premises
Cloud-Based
6.3. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disease Risk Assessment
Drug Discovery
Personalized Medicine
Genomic Data Analysis
Other Applications
6.4. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Research Institutes
Healthcare Providers
Other End-Users
6.5. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Computing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gate Based Quantum Computing
Quantum Annealing
Topological Quantum Computing
Photonic Quantum Computing
6.6. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Machine Learning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Supervised Learning
Unsupervised Learning
Reinforcement Learning
Deep Learning
6.7. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Cryptography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantum Key Distribution
Quantum Random Number Generation
Quantum Secure Communication
Post Quantum Cryptograp
6.8. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantum Sensors
Quantum Simulation
Quantum Networking
Hybrid Quantum Classical Systems
7. Quantum-Enhanced Predictive Genomics Market Regional And Country Analysis
7.1. Global Quantum-Enhanced Predictive Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Quantum-Enhanced Predictive Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Quantum-Enhanced Predictive Genomics Market
9.1. China Quantum-Enhanced Predictive Genomics Market Overview
9.2. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Quantum-Enhanced Predictive Genomics Market
10.1. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Quantum-Enhanced Predictive Genomics Market
11.1. Japan Quantum-Enhanced Predictive Genomics Market Overview
11.2. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Quantum-Enhanced Predictive Genomics Market
12.1. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Quantum-Enhanced Predictive Genomics Market
13.1. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Quantum-Enhanced Predictive Genomics Market
14.1. South Korea Quantum-Enhanced Predictive Genomics Market Overview
14.2. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Quantum-Enhanced Predictive Genomics Market
15.1. Western Europe Quantum-Enhanced Predictive Genomics Market Overview
15.2. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Quantum-Enhanced Predictive Genomics Market
16.1. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Quantum-Enhanced Predictive Genomics Market
21.1. Eastern Europe Quantum-Enhanced Predictive Genomics Market Overview
21.2. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Quantum-Enhanced Predictive Genomics Market
22.1. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Quantum-Enhanced Predictive Genomics Market
23.1. North America Quantum-Enhanced Predictive Genomics Market Overview
23.2. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Quantum-Enhanced Predictive Genomics Market
24.1. USA Quantum-Enhanced Predictive Genomics Market Overview
24.2. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Quantum-Enhanced Predictive Genomics Market
26.1. South America Quantum-Enhanced Predictive Genomics Market Overview
26.2. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Quantum-Enhanced Predictive Genomics Market
27.1. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Quantum-Enhanced Predictive Genomics Market
28.1. Middle East Quantum-Enhanced Predictive Genomics Market Overview
28.2. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Quantum-Enhanced Predictive Genomics Market
29.1. Africa Quantum-Enhanced Predictive Genomics Market Overview
29.2. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Quantum-Enhanced Predictive Genomics Market Competitive Landscape And Company Profiles
